Product
Fondaparinux
3 clinical trials
4 indications
Indication
ThrombosisIndication
Leg InjuryIndication
Superficial ThrombophlebitisIndication
EVLAClinical trial
Thromboprophylaxis in Lower Limb Immobilisation (TiLLI): a Multicentre Study Comprising Two Linked Open Label Phase III Randomised Controlled Trials Evaluating the Effectiveness and Cost Effectiveness of Different Methods of Pharmacological Prophylaxis for Patients With Temporary Lower Limb Immobilisation.Status: Not yet recruiting, Estimated PCD: 2028-02-01
Clinical trial
Choice of the Optimal Method for Treatment of Acute Thrombophlebitis of the Varicose Great Saphenous Vein: Comparison of Endovenous Laser Ablation and Conservative ApproachStatus: Completed, Estimated PCD: 2023-12-01
Clinical trial
Superficial Vein Thrombosis (SVT) Treated for Forty-five Days With Rivaroxaban Versus FondaparinuxStatus: Completed, Estimated PCD: 2016-05-01